Heartwood Wealth Advisors LLC Cuts Position in The Procter & Gamble Company (NYSE:PG)

Heartwood Wealth Advisors LLC reduced its holdings in The Procter & Gamble Company (NYSE:PG) by 7.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,786 shares of the company’s stock after selling 283 shares during the period. Heartwood Wealth Advisors LLC’s holdings in Procter & Gamble were worth $635,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Itau Unibanco Holding S.A. acquired a new stake in Procter & Gamble during the 2nd quarter worth $28,000. Fairway Wealth LLC acquired a new stake in Procter & Gamble in the 2nd quarter valued at about $29,000. RPg Family Wealth Advisory LLC purchased a new position in Procter & Gamble in the 3rd quarter worth approximately $33,000. Quest Partners LLC purchased a new stake in shares of Procter & Gamble in the second quarter valued at approximately $36,000. Finally, Fairfield Financial Advisors LTD purchased a new position in Procter & Gamble during the second quarter worth approximately $44,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock traded down $4.58 on Friday, hitting $157.52. The company’s stock had a trading volume of 4,299,350 shares, compared to its average volume of 6,154,908. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The firm has a fifty day moving average price of $169.77 and a 200-day moving average price of $169.64. The Procter & Gamble Company has a 52-week low of $146.28 and a 52-week high of $180.43. The company has a market capitalization of $370.97 billion, a P/E ratio of 27.16, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter last year, the business posted $1.83 earnings per share. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. On average, equities research analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. The trade was a 52.53 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 75,439 shares of company stock valued at $13,317,460. Insiders own 0.18% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on PG. Morgan Stanley boosted their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Piper Sandler assumed coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Wells Fargo & Company lowered their target price on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a report on Tuesday. Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research note on Monday, September 30th. Finally, JPMorgan Chase & Co. upped their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $179.75.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.